Axillary injection of botulinum A toxin in a patient with muscle cramps associated with severe axillary hyperhidrosis.
نویسندگان
چکیده
Muscle cramps may be caused by fluid and salt loss induced by diffuse or focal hyperhidrosis. Recent reports have described the efficacy of botulinum, toxin in the treatment of primary focal hyperhidrosis. Botulinum toxin inhibits sweating by blocking exocytosis of acetylcholine from presynaptic cholinergic nerve terminals. We report the case of a patient who complained of frequent muscle cramps associated with unusually severe axillary hyperhidrosis. We used botulinum toxin to treat the excessive focal sweating presuming that it would also reduce the muscle cramps. A total dose of 200 MU of botulinum A toxin (Dysport) per axilla markedly reduced sweating and cramps. The beneficial effect started four days after the injection and it was still present five months later. Treatment was repeated in the sixth month with analogous results. No side-effects were observed and no compensatory sweating occurred.
منابع مشابه
Treatment of severe axillary Hyperhidrosis with Botulinum toxin A
Background: Severe axillary hyperhidrosis causes considerable emotional stress to individuals affected with this condition. Existing topical and surgical therapies are either ineffective or associated with unacceptable morbidity and sequelae. Objective: In this study we attempted to determine the effect of botulinum toxin A (Dysport) in the treatment of axillary hyperhidrosis. Patients and Meth...
متن کاملBotulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.
Hyperhidrosis is a common disorder that may have a severe impact on quality of life. The aim of this study was to investigate the clinical effect of two novel botulinum toxins, Xeomin®, a type A botulinum toxin, and Neuro-bloc®, a type B botulinum toxin, in the treatment of axillary and palmar hyperhidrosis. A total of 84 patients, 58 with axillary and 26 with palmar hyperhidrosis, were include...
متن کاملBotulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial.
OBJECTIVES To evaluate the safety and efficacy of botulinum toxin type A in the treatment of bilateral primary axillary hyperhidrosis. DESIGN Multicentre, randomised, parallel group, placebo controlled trial. SETTING 17 dermatology and neurology clinics in Belgium, Germany, Switzerland, and the United Kingdom. PARTICIPANTS Patients aged 18-75 years with bilateral primary axillary hyperhid...
متن کاملLower relapse rate of botulinum toxin A therapy for axillary hyperhidrosis by dose increase.
BACKGROUND Primary focal hyperhidrosis is a common condition that gives rise to functional and emotional problems and may disturb professional and social life. Recently, low-dose intracutaneous injections of botulinum toxin A have been shown to induce a temporary anhidrosis, with relapses occurring usually after 4 to 6 months. OBJECTIVE To evaluate the short- and long-term effectiveness and p...
متن کاملSocial factors associated with child mental health problems in Brazil: cross sectional survey.
controlled intradermal injection of botulinum toxin type A in recalcitrant axillary hyperhidrosis. J Am Acad Dermatol 1999;41:987-90. 8 Naumann M, Flachenecker P, Bröcker E-B, Toyka KV, Reiners K. Botulinum toxin for palmar hyperhidrosis. Lancet 1997;349:252. 9 Naumann M, Hofmann U, Bergmann I, Hamm H, Toyka KV, Reiners K. Focal hyperhidrosis: effective treatment with intracutaneous botulinum t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Acta neurologica Belgica
دوره 101 2 شماره
صفحات -
تاریخ انتشار 2001